Strides Shasun gets approval for Tenofovir Disoproxil Fumarate Tablets

From USFDA

Strides Shasun announced that its wholly owned subsidiary Strides Pharma Globe has received approval for Tenofovir Disoproxil Fumarate Tablets, 300 mg from the United States Food & Drug Administration.

Tenofovir Disoproxil Fumarate is a generic version of Gileads's Viread Tablet, for which patent expired on 25 January 2018. Strides is launching the product immediately.

Powered by Capital Market - Live News